Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population

PURPOSE: HPV4 is the most expensive vaccine requiring three appropriately timed doses to provide maximal efficacy against two oncogenic HPV types. The primary purpose of this study is to quantify the use of HPV4 vaccine in a safety net health care system in terms of its inefficiencies. METHODS: A re...

Descripción completa

Detalles Bibliográficos
Autores principales: Harper, Diane M., Verdenius, Inge, Ratnaraj, Felicia, Arey, Anne M., Rosemergey, Beth, Malnar, Gerard J., Wall, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819328/
https://www.ncbi.nlm.nih.gov/pubmed/24223131
http://dx.doi.org/10.1371/journal.pone.0077961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819328/
https://www.ncbi.nlm.nih.gov/pubmed/24223131
http://dx.doi.org/10.1371/journal.pone.0077961

Ejemplares similares